| Alector | Phase 3 | $244.3M | Neurodegenerative Diseases, Neurology |
| Third Harmonic Bio | Phase 1b | $240M | Allergy & Immunology, Inflammatory Diseases |
| Lomond Therapeutics | Pre-clinical | — | Oncology, Hematology |
| Edge Medical | commercial | — | Surgery |
| Zion Pharma | phase-1 | — | Oncology |
| NewBiologix | phase-1 | — | Rare Disease, Genetics & Genomics |
| ReCode Therapeutics | phase-1 | — | Respiratory, Metabolic |
| QL Biopharm | preclinical | — | Oncology |
| Eccogene | phase-2 | — | Metabolic, Immunology |
| CHARM Therapeutics | preclinical | — | Oncology |
| ImageneBio | Phase 2 | — | Immunological Diseases, Autoimmune Diseases |
| Navire Pharma | Phase 1 | — | Oncology |
| Vanqua Bio | Pre-clinical | — | Parkinson's Disease, Alzheimer's Disease |
| Helicore Biopharma | Pre-clinical | — | Obesity, Metabolic Disease |
| Eilean Therapeutics | Pre-clinical | — | Oncology, Hematology |
| Verdiva Bio | Phase 2 | — | Obesity, Cardiometabolic Disorders |
| Renasant Bio | Pre-clinical | — | Nephrology, Genetic Disorders |
| Terremoto Biosciences | Phase 1 | — | Oncology, Genetic Disease |
| Alterome Therapeutics | Phase 1 | — | Oncology |
| Brenig Therapeutics | Phase 1 | — | Neurodegenerative Diseases, Parkinson's Disease |
| Mondego Bio | Pre-clinical | — | Oncology, Immunology |
| GentiBio | Phase 1 | — | Type 1 Diabetes, Autoimmune Diseases |
| Sirius Therapeutics | Phase 2 | — | Cardiovascular, Metabolic Disease |
| RayThera | Pre-clinical | — | Immunology, Inflammation |
| ProLynx | Pre-clinical | — | Obesity, Metabolic Diseases |
| QuantX Biosciences | Pre-clinical | — | Immunology, Inflammation |
| TransThera Sciences | phase-2 | — | Oncology, Immunology |
| Biosion | phase-2 | — | Oncology, Immunology |
| Quaero Life Science | phase-2 | — | Oncology, Immunology |
| ProfoundBio | phase-2 | — | Oncology |
| Alveus Therapeutics | preclinical | — | Respiratory, Pulmonology |
| Mwyngil Therapeutics | preclinical | — | Obesity, Chronic Kidney Disease |
| Callio Therapeutics | preclinical | — | Rare Neurological Diseases, Mitochondrial Disorders |
| GeneCure | phase-1 | — | Rare Disease, Genetics & Genomics |
| Immunai | platform | — | Oncology, Immunology |
| OncoTarget | phase-2 | — | Oncology |
| Premia Spine | preclinical | — | Spinal Disorders, Orthopedics |
| GenoDx | commercial | — | Oncology |
| Alebund Pharmaceutical | phase-2 | — | Metabolic, Rare Disease |
| IceCure Medical | commercial | — | Oncology, Interventional Oncology |
| Mirador Therapeutics | preclinical | — | Immunology, Respiratory |